Fleebs-Logo
Details werden geladen...

What RevMed's pancreatic cancer drug meant for one patient

Why did a presentation on Revolution Medicines' pancreatic cancer drug get a standing ovation? Why did biotech stocks perform so badly this week? Find out on "The Readout LOUD."

Ähnliche Seiten

https://www.statnews.com/2026/05/30/pancreatic-cancer-daraxonrasib-revolution-medicines-early-access-asco-2026/

Revolution Medicines starts early access for pancreatic cancer drug | STAT

https://www.statnews.com/2026/05/30/pancreatic-cancer-daraxonrasib-revolution-medicines-early-access-asco-2026/
https://www.statnews.com/2026/06/04/revolution-medicines-daraxonrasib-pancreatic-cancer/

Does Revolution Medicines' pancreatic cancer drug have even greater potential?

https://www.statnews.com/2026/06/04/revolution-medicines-daraxonrasib-pancreatic-cancer/
https://www.bmj.com/content/393/bmj-2026-902114

Pancreatic cancer: New drug results prompt standing ovation at oncology conference | The BMJ

https://www.bmj.com/content/393/bmj-2026-902114